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Abstract: Naturally occurring nootkatone, with reported insecticidal and acaricidal properties,
has been used as a lead to generate molecular diversity and, consequently, new insect antifeedant
and ixodicidal compounds. A total of 22 derivatives were generated by subjecting this molecule
to several reactions including dehydrogenation with the iodine/DMSO system, oxidation with
SeO2, epoxidation with mCPBA, oxidation or carbon homologations of the α-carbonyl position with
TMSOTf (trimethylsilyl trifluoromethanesulfonate) followed by Rubottom and Dess Martin periodane
oxidations, condensation with formaldehyde using Yb(OTf)3 as catalyst and dehydroxilation using the
Grieco protocol. The insect antifeedant (against Myzus persicae and Ropaloshysum padi) and ixodicidal
(against the tick Hyalomma lusitanicum) activities of these compounds were tested. Compound 20 was
the most active substance against M. persicae and R. padi, and twice more efficient than nootkatone in
the antitick test.
Keywords: organic synthesis; natural products; pesticides; antiticks; antifeedant
1. Introduction
The well-known advantages of biopesticides compared to conventional synthetic pesticides account
for the increasing number of research papers published in this field in recent years [1,2]. Conventional
pesticides and biopesticides can be categorized according to the origin of their active ingredients,
with one of these categories encompassing synthetic natural derived (SND) substances [2]. In this
context, we focused our attention on nootkatone (1), a sesquiterpene which was isolated for the first
time from the essential oil of the heartwood of Alaska yellow cedar (Cupressus nootkatensis) [3,4], and is
also present in plants of Citrus genus [5], Vetiveria species [6] and others natural sources [7]. Our interest
in this molecule was based on its very interesting insecticidal and acaricidal properties [4,8–14]. In this
sense, formulations acting as pesticides against mosquitoes and ticks are currently being developed [15].
However, the mode of action of this product remain uncertain [16].
Considering the repellent effects and insecticidal activity of nootkatone, we planned to use this
renewable and chiral molecule as natural lead to generate molecular diversity with the ultimate goal
of obtaining new SND insect antifeedants (against Rhopalosiphum padi, Myzus persicae, Spodoptera
littoralis) and ixodicidal (against Hyalomma lusitanicum) compounds. The moth S. littoralis, also known
as Egyptian cotton leaf worm, is reported to be a pest of this plant and of a high variety of vegetable
crops [17]. The aphid M. persicae is known to infect many species from 40 plant families, with special
prevalence in Brassica crops [18]. R. padi is also an aphid and is considered one of the most important
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cereal pest [19]. Hyalomma lusitanicum is a tick mainly found throughout the Mediterranean area.
Apart from its widely known detrimental effects on several species of cattle, this pest is an efficient
vector transmitter of the Crimean–Congo hemorrhagic fever disease [20].
Nootkatone features an appropriate structure with functionalizations that may allow an easy
and efficient synthesis of a series of derivatives following a Diversity Oriented Synthesis (DOS)
approach [21]. Thus, the presence of an unsaturated ketone would enable the production of further
insaturations at C3–C4 or C8–C9. Also, the carbonyl group at C2 should permit the generation of new
derivatives functionalized at C3. Additionally, the direct and allylic oxidations of the double bonds
present in the molecule will help increase structural diversity (Figure 1).
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Figure 1. Generation of structural diversity from nootkatone (1). 
To improve persistence of biological activity in open areas, new less volatile oxygenated 
nootkatone derivatives have been designed. 
2. Experimental 
2.1. Chemicals and Instrument 
Silica gel 60 (35–70 μm) was used for flash column chromatography. NMR spectra (see 
Supplementary Materials) were obtained in a Varian Direct-Drive 600 (1H 600 MHz/13C 150 MHz), 
Varian Direct-Drive 500 (1H 500 MHz/13C 125 MHz) and Varian Direct-Drive 400 (1H 400 MHz/13C 
100 MHz). Accurate mass determinations were performed on a SYNAPT G2-Si Q-TOF mass 
spectrometer (Waters, Milford, MA, USA) equipped with high-efficiency T-Wave ion mobility and 
an orthogonal Z–spray™ electrospray ionization (ESI) source. MassLynx v.4.1 software was used for 
HRMS instrument control, peak detection, and integration. Reactions were monitored by TLC on 
0.25-mm E. Merck silica gel plates (60F-254) visualized under UV light and by applying a 
phosphomolybdic acid solution in EtOH followed by heat. High quality reagents were purchased at 
the highest quality that was commercially available and were used without further purification. 
2.2. Synthesis of Nootkatone Derivatives (See Table 1, Scheme 1) 
2.2.1. Dehydrogenation of Nootkatone with the System I2/Dimethysulfoxide (DMSO) 
To a solution of nootkatone (1), (219 mg, 1 mmol) in toluene (10 mL), I2 (25 mg, 0.1 mmol) and 
DMSO (0.34 mL, 5 mmol) were added under argon atmosphere. The resulting mixture was refluxed 
for 6 h. Upon consumption of the starting material, the reaction mixture was diluted with methyl tert-
butyl ether (MTBE) (60 mL), washed with saturated Na2S2O4 (3 × 30 mL), brine (3 × 30 mL), dried over 
anhydrous Na2SO4, and concentrated in vacuo. The crude product was purified by flash 
chromatography (H:MTBE 4:1) to obtain 2 [22] (31 mg, 14%), 3 [23] (110 mg, 51%) and 4 (56 mg, 16%). 
Compound 4: [α]D = +34.3 (c = 1, DCM). 1H NMR (600 MHz CDCl3) δ 6.23 (dd, J = 10.3, 2.3 Hz, 
1H), 6.20 (d, J = 10.3 Hz, 1H), 5.84 (s, 1H), 4.94 (d, J = 12.5 Hz, 1H), 4.87 (s, 1H), 4.82 (s, 1H), 3.03 (dd, J 
= 11.3, 4.6 Hz, 1H), 2.28 (dq, J = 13.2, 6.7 Hz, 1H), 2.03 (dd, J = 12.9, 4.9 Hz, 1H), 1.75 (s, 3H), 1.33 (t, J = 
12.2 Hz, 1H), 1.27 (d, J = 6.7 Hz, 3H), 1.08 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 192.88 (C), 161.97 (C), 
146.81 (C), 141.63 (CH), 127.53 (CH), 121.74 (CH), 112.01 (CH2), 48.70 (CH), 41.80 (CH), 41.67 (CH), 
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improve persistence of biological activity in open areas, new less volatile oxygenated nootkatone
derivatives have been designed.
2. Experimental
2.1. Chemicals and Instrument
Silica gel 60 (35–70 µm) was used for flash column chromatography. NMR spectra (see
Supplementary Materials) were obtained in a Varian Direct-Drive 600 (1H 600 MHz/13C 150 MHz), Varian
Direct-Drive 500 (1H 500 MHz/13C 125 MHz) and Varian Direct-Drive 400 (1H 400 MHz/13C 100 MHz).
Accurate mass determinations were performed on a SYNAPT G2-Si Q-TOF mass spectrometer (Waters,
Milford, MA, USA) equipped with high-efficiency T-Wave ion mobility and an orthogonal Z–spray™
electrospray ionization (ESI) source. MassLynx v.4.1 software was used for HRMS instrument control,
peak detection, and integration. Reactions were monitored by TLC on 0.25-mm E. Merck silica gel
plates (60F-254) visualized under UV light and by applying a phosphomolybdic acid solution in EtOH
followed by heat. High quality reagents were purchased at the highest quality that was commercially
available and were used without further purification.
2.2. Synthesis of Nootkatone Derivatives (See Table 1, Scheme 1)
2.2.1. Dehydrogenation of Nootkatone with the System I2/Dimethysulfoxide (DMSO)
To a solution of nootkatone (1), (219 mg, 1 mmol) in toluene (10 mL), I2 (25 mg, 0.1 mmol) and
DMSO (0.34 mL, 5 mmol) were added under argon atmosphere. The resulting mixture was refluxed
for 6 h. Upon consu ption of the starting material, the reaction mixture was diluted with methyl
tert-butyl ether (MTBE) (60 mL), washed with saturated Na2S2O4 (3 × 30 mL), brine (3 × 30 mL),
dried over anhydrous Na2SO4, and concentrated in vacuo. The crude product was purified by flash
chromatography (H:MTBE 4:1) to obtain 2 [22] (31 mg, 14%), 3 [23] (110 mg, 51%) and 4 (56 mg, 16%).
Compound 4: [α]D = +34.3 (c = 1, DCM). 1H NMR (600 MHz CDCl3) δ 6.23 (dd, J = 10.3, 2.3 Hz,
1H), 6.20 (d, J = 10.3 Hz, 1H), 5.84 (s, 1H), 4.94 (d, J = 12.5 Hz, 1H), 4.87 (s, 1H), 4.82 (s, 1H), 3.03 (dd,
J = 11.3, 4.6 Hz, 1H), 2.28 (dq, J = 13.2, 6.7 Hz, 1H), 2.03 (dd, J = 12.9, 4.9 Hz, 1H), 1.75 (s, 3H), 1.33 (t,
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J = 12.2 Hz, 1H), 1.27 (d, J = 6.7 Hz, 3H), 1.08 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 192.88 (C), 161.97
(C), 146.81 (C), 141.63 (CH), 127.53 (CH), 121.74 (CH), 112.01 (CH2), 48.70 (CH), 41.80 (CH), 41.67 (CH),
39.44 (CH2), 38.71 (C), 20.47 (CH3), 17.62 (CH3), 16.99 (CH3). HRMS TOF (ESI+) m/z calculated for
C15H19IO [M + H]+ 342.0475, found 342.0481.
2.2.2. Dehydrogenation of 1 with 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ)
To a solution of nootkatone 1 (655 mg, 3 mmol) in 20 mL of benzene, under an argon atmosphere,
was added DDQ (749 mg, 3.3 mmol) and 0.22 mL of acid acetic. The reaction mixture was stirred for 2
days in reflux. Then, the solution was filtered at room temperature and the solvent was evaporated
under low pressure. The crude reaction mixture was then re-dissolved in EtOAc, and washed with
saturated NaHCO3 and brine, dried with anhydrous Na2SO4, and concentrated in vacuo. Purification
by flash chromatography (H:MTBE, 1:1) provided 328 mg of 3 [23] (51%) and 103 mg of 1 (16%).
2.2.3. Reaction of Nootkatone with SeO2 (See Scheme 2)
To a solution of nootkatone 1 (216 mg, 0.99 mmol) in EtOH (10 mL), SeO2 (100 mg, 1 mmol) was
added and the resulting solution was refluxed for 3 h. Upon consumption of the starting material,
the reaction mixture was concentrated in vacuo. The crude reaction mixture was solubilized in EtOAc
(50 mL), washed with saturated NaHCO3 (3 × 30 mL), brine (3 × 30 mL), dried over anhydrous Na2SO4,
and concentrated in vacuo. Purification by flash chromatography was carried out (H:MTBE, from 4:1
to 1:1) to give 75 mg of 5 [24] (32%), 28 mg of 6 [24] (11%) and 35 mg of 7 (15%).
Compound 7. [α]D= −0.39 (c = 1, DCM). 1H NMR (500 MHz, CDCl3) δ 4.94 (s, 1H), 4.80 (s,
1H), 2.69 (d, J = 16.3 Hz, 1H), 2.56 (d, J = 16.4 Hz, 1H), 2.26–2.12 (m, 4H), 1.77 (s, 3H), 1.72–1.77 (m,
3H), 1.54–1.45 (m, 2H), 1.11 (d, J = 0.8 Hz, 3H), 0.90 (d, J = 5.8 Hz, 3H). 13C NMR (126 MHz, CDCl3)
δ = 209.05 (C), 145.62 (C), 109.61 (CH2), 89.89 (C), 88.66 (C), 49.73 (CH2), 45.91 (C), 44.66 (CH2), 44.35
(CH2), 37.96 (CH), 35.92 (CH2), 32.85 (CH2), 18.91 (CH3), 15.33 (CH3), 14.27 (CH3). HRMS TOF (ESI+)
m/z calculated for C15H23O2 [M + H]+ 235.1691, found 235.1698.
2.2.4. Acetylation of Compound 5
To a solution of 5 (300 mg, 1.28 mmol) in pyridine (10 mL), 3 mg of 4-dimethhylaminopyridine
were added under argon atmosphere and the resulting mixture was heated to reflux temperature.
Then Ac2O (1.82 mL, 19.2 mmol) was added and the mixture refluxed for 1 h. Upon consumption of
the starting material, 10 g of ice and 50 mL of MTBE were poured over the crude mixture. The organic
layer was washed with 2N HCl (3 × 30 mL), saturated NaHCO3 (3 × 30 mL) and brine (3 × 30 mL),
dried over anhydrous Na2SO4, and concentrated in vacuo. The crude product was purified by flash
chromatography (H:MTBE, 1:2) to give 291 mg of 8 (82%).
Compound 8. [α]D= +99.8 (c = 1, DCM). 1H NMR (400 MHz, CDCl3) δ 5.75 (s, 1H), 5.07 (s, 1H),
4.96 (s, 1H), 4.56 (s, 2H), 2.50 (dddd, J = 15.6, 13.7, 5.1, 2.0 Hz, 1H), 2.43–2.29 (m, 2H), 2.29–2.16 (m,
2H), 2.08 (s, 3H), 2.06–1.87 (m, 3H), 1.35 (dd, J = 13.6, 12.6, 4.2 Hz, 1H), 1.25–1.10 (m, 1H), 1.09 (s, 3H),
0.94 (d, J = 6.8 Hz, 3H).13C NMR (101 MHz, CDCl3) δ = 199.35 (C), 170.64 (C), 169.63 (C), 147.34 (C),
124.83 (CH2), 111.83 (CH), 66.01 (CH2), 44.15 (CH2), 42.00 (CH2), 40.36 (CH), 39.33 (C), 36.37 (CH),
32.90 (CH2), 31.74 (CH2), 20.93 (CH3), 16.70 (CH3), 14.85(CH3). HRMS TOF (ES+) m/z calculated for
C17H25O3 [M + H]+ 277.1804, found 277.1831.
2.2.5. Reaction of Compound 3 with SeO2 (See Scheme 3)
To a solution of 3 (115 mg, 0.53 mmol) in EtOH (5 mL), SeO2 (96 mg, 0.86 mmol) was added
and the resulting solution was the refluxed for 3 h. The reaction mixture was then concentrated in
vacuo, re-dissolved in EtOAc (30 mL), washed with saturated NaHCO3 (3 × 20 mL), brine (3 × 20 mL),
dried over anhydrous Na2SO4, and concentrated in vacuo. The crude product was purified by flash
chromatography (H:MTBE, from 1:2 to 1:4) to obtain 30 mg of 3 (26%), 65 mg of 9 (53%) and 17 mg of
10 (14%).
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Compound 9. [α]D= +29.6 (c = 1, DCM). 1H NMR (500 MHz, CDCl3) δ = 6.11 (s, 2H), 5.10 (s, 1H),
4.90 (s, 1H), 4.16 (s, 2H), 2.71–2.54 (m, 2H), 2.50 (dddd, J = 15.6, 13.7, 5.1, 2.0 Hz, 1H), 2.18–2.03 (m,
2H), 2.01 (s, 3H), 1.47–1.36 (m, 1H), 1.36 (s, 3H), 1.28 (t, J = 12.8 Hz, 1H). 13C NMR (126 MHz, CDCl3)
δ = 186.39 (C), 167.10 (C), 165.66 (C), 151.57 (C), 126.78 (CH), 124.61 (CH), 109.82 (CH2), 65.30 (CH2),
43.46 (C), 42.40 (CH2), 35.72 (CH), 33.90 (CH2), 32.85 (CH2), 23.24 (CH3), 18.86 (CH3). HRMS TOF
(ESI+) m/z calculated for C15H21O2 [M + H]+ 233.1542, found 233.1671.
Compound 10. [α]D= +40.6 (c = 1, DCM). 1H NMR (500 MHz, CD3COCD3) δ 9.59 (s, 1H), 6.42
(d, J = 1.1 Hz, 1H), 6.18 (s, 1H), 6.00 (dt, J = 4.8, 1.7 Hz, 2H), 3.12 (ttd, J = 12.7, 3.5, 1.1 Hz, 1H), 2.77
(ddd, J = 13.8, 4.9, 1.7 Hz, 1H), 2.46 (ddd, J = 13.9, 4.2, 2.6 Hz, 1H), 2.16 (ddd, J = 12.7, 3.5, 2.3 Hz,
1H), 2.05–1.99 (m, 4H), 1.44 (s, 3H), 1.43–1.37 (m, 1H), 1.26 (t, J = 12.7 Hz, 1H). 13C NMR (126 MHz,
CD3COCD3) δ 194.04 (CH), 184.78 (C), 166.14 (C), 164.92 (C), 153.28 (C), 133.45 (CH2), 126.35 (CH),
124.30 (CH), 43.25 (C), 41.72 (CH2), 33.16 (CH2), 32.23 (CH2), 30.77 (CH), 22.66 (CH3), 17.89 (CH3).
HRMS TOF (ESI+) m/z calculated for C15H19O2 [M + H]+ 231.1382, found 231.1385.
2.2.6. Reaction of Nootkatone with mchloroperbenzoic Acid (mCPBA) (See Scheme 4)
To a solution of nootkatone (1) (220 mg, 1 mmol) in DCM (6 mL), mCPBA (595 mg, 3.4 mmol)
was added and stirred at room temperature for 5 days. Upon consumption of the starting material,
the reaction mixture was diluted with MTBE (50 mL), washed with 10% Na2SO3 (3 × 30 mL), 10%
NaOH (3 × 30 mL) and brine (3 × 30 mL), dried over anhydrous Na2SO4, and concentrated in vacuo.
The crude product was purified by flash chromatography (H:MTBE, 3:1) to obtain 49 mg of 11 [25]
(21%), 58 mg of 12 [26] (23%) and 79 mg of 13 (30%).
Compound 13. [α]D= +5.5 (c = 1, DCM). 1H NMR (400 MHz, CDCl3) δ 4.78 (s, 2H), 2.89 (m, 2H),
2.64–2.52 (m, 4H), 2.43–2.37 (m, 2H), 1.92–1.74 (m, 8H), 1.67–1.44 (m, 2H), 1.38–1.15 (m, 6H), 1.25 (s,
3H), 1.24 (s, 3H), 1.08 (s, 3H), 1.08 (s, 3H), 0.99 (d, J = 7.2, Hz, 3H), 0.98 (d, J = 7.2, Hz, 3H). 13C NMR
(101 MHz, CDCl3) δ = 170.35, 170.31 (C), 86.80, 86.68 (CH), 69.13, 69.05 (C), 58.76, 58.59 (C), 53.50, 52.87
(CH2), 40.60, 40.37 (CH2), 38.65 (CH2), 38.37, 37.87 (CH), 38.23 (C), 37.64, 37.62 (CH), 30.78, 30.61 (CH2),
26.21, 25.73 (CH2), 18.54, 17.92 (CH3), 17.12, 17.07 (CH3), 16.60, 16.58 (CH3). HRMS TOF (ES+) m/z
calculated for C15H23O4 [M + H]+ 267.1583, found 267.1596.
2.2.7. Synthesis of Compounds 14 and 15 (See Scheme 5)
To a solution of nootkatone 1 (0.46 mL, 2 mmol) in dry toluene (9 mL) at −78 ◦C, 2.5 mL of collidine
were added and stirred for 15 min, then TMSOTf (0.9 mL, 5 mmol) was added and the resulting solution
was stirred for additional 10 min. Upon consumption of the starting material, the reaction mixture was
diluted with hexane (15 mL), washed with brine (3 × 10 mL) and dried over anhydrous Na2SO4 and
concentrated in vacuo. The crude product was solved in dry DCM (30 mL) at 0 ◦C and then NaHCO3
(672 mg, 8 mmol) and mCPBA (592 mg, 2,4 mmol) were added. The resulting mixture was stirred for 3
h. The reaction mixture was then diluted with DCM (5 mL) filtered through Celite®and concentrated
in vacuo. The crude product was purified using mixtures of eluents of increasing polarity to obtain
30 mg of 1 (7%) (H:MTBE 9:1), 76 mg of 14 (16%) (H:MTBE, 5:1) and 77 mg of 15 (16%) (H:MTBE,5:1).
Compound 14. [α]D= +137.8 (c = 1, DCM). 1H NMR (600 MHz, CDCl3) δ = 5.85 (s, 1H), 4.74 (s,
1H), 4.70 (s, 1H), 3.96 (d, J = 12.7 Hz, 1H), 2.52 (td, J = 13.7, 4.5 Hz, 1H), 2.40 (ddd, J = 14.9, 4.2, 2.6 Hz,
1H), 2.34 (tt, J = 12.5, 3.3 Hz, 1H), 1.97 (dt, J = 13.1, 2.9 Hz, 1H), 1.91–1.95 (m, 1H), 1.82 (dq, J = 13.2, 6.7
Hz, 1H), 1.72 (s, 3H), 1.36 (qd, J = 12.9, 4.2 Hz, 1H), 1.22 (s, 3H), 1.14 (d, J = 6.7 Hz, 3H). 13C NMR (151
MHz, CDCl3) δ = 199.65 (C), 172.08 (C), 148.63 (C), 120.98 (CH), 109.46 (CH2), 73.40 (CH), 47.63 (CH),
44.18 (CH2), 40.92 (C), 39.61 (CH), 33.14 (CH2), 31.75 (CH2), 20.75 (CH3), 17.79 (CH3), 10.81 (CH3).
HRMS TOF (ESI+) m/z calculated for C15H23O2 [M + H]+ 235.1689, found 235.1698.
Compound 15. [α]D= -49.8 (c = 1, DCM). 1H NMR (400 MHz, CDCl3) δ = 5.82 (s, 1H), 4.72 (s, 1H),
4.70 (s, 1H), 4.36 (d, J = 5.2 Hz, 1H), 2.62–2.46 (m, 2H), 2.27 (ddd, J = 12.7, 4.3, 2.7 Hz, 1H), 2.07–1.96 (m,
2H), 1.83–1.71 (m, 2H), 1.70 (s, 3H), 1.37–1.28 (m, 1H), 1.26 (s, 3H), 0.91 (d, J = 7.0 Hz, 3H).13C NMR
(151 MHz, CDCl3) δ = 199.59 (C), 170.58 (C), 148.13 (C), 119.46 (CH), 109.69 (CH2), 73.23 (CH), 43.87
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(CH), 43.58 (CH2), 41.11 (C), 39.91 (CH), 34.37 (CH2), 32.98 (CH2), 22.54 (CH3), 20.93 (CH3), 8.86 (CH3).
HRMS TOF (ESI+) m/z calculated for C15H23O2 [M + H]+ 235.1689, found 235.1709.
2.2.8. Synthesis of Compounds 16 and 17
To a solution of the compounds 14 and 15 (40 mg, 0.17 mmol) dry DCM (1 mL), DMP (89 mg,
0.21 mmol) was added under argon atmosphere. The mixture was stirred for 90 min. Then, a saturated
solution of Na2S2O3-NaHCO3 (3 mL) was added and the resulting mixture was stirred for 30 additional
min. Upon consumption of the starting material, the reaction mixture was diluted in MTBE (10 mL),
washed with NaHCO3 (3× 7 mL) and brine (3× 7 mL), dried with anhydrous Na2SO4, and concentrated
in vacuo. Purification by flash chromatography (H:TMBE, 3:1) gave 10 mg of 16 (23%) and 6 mg of 17
(14%).
Compound 16. [α]D= −10.4 (c = 1, DCM). 1H NMR (400 MHz, CDCl3) δ = 6.47 (s, 1H), 6.22 (s,
1H), 4.76 (s, 1H), 4.74 (s, 1H), 2.63 (td, J = 13.8, 5.0 Hz, 1H), 2.51–2.41 (m, 2H), 2.11 (dt, J = 13.0, 3.0 Hz,
1H), 2.08–2.01 (m, 1H), 1.97 (s, 3H), 1.72 (s, 3H), 1.41–1.35 (m, 1H), 1.34 (s, 3H), 1.20 (t, J = 12.8 Hz, 1H).
13C NMR (126 MHz, CDCl3) δ = 180.44 (C), 170.50 (C), 147.92 (C), 143.85 (C), 134.29 (C), 121.51 (CH),
110.01 (CH2), 43.50 (C), 42.53 (CH2), 39.87 (CH), 33.63 (CH2), 32.98 (CH2), 23.220 (CH3), 20.66 (CH3),
10.81 (CH3). HRMS TOF (ES+) m/z calculated for C15H21O2 [M + H]+ 233.1542, found 233.1531.
Compound 17. [α]D= +105.2 (c = 1, DCM). 1H NMR (400 MHz, CDCl3) δ = 6.19 (s, 1H), 4.79 (s,
1H), 4.77 (s, 1H), 2.63 (dddd, J = 15.2, 13.3, 5.1, 1.9 Hz, 1H), 2.55 (ddd, J = 14.9, 4.4, 2.6 Hz, 1H), 2.41 (tt,
J = 12.6, 3.5 Hz, 1H), 2.06–1.97 (m, 1H), 1.89 (t, J = 12.9 Hz, 1H), 1.84–1.77 (m, 1H), 1.76 (s, 3H), 1.54–1.43
(m, 1H), 1.42 (s, 3H), 1.29 (s, 3H).13C NMR (126 MHz, CDCl3) δ = 197.15 (C), 186.11 (C), 172.62 (C),
148.08 (C), 124.92 (CH), 110.03 (CH2), 81.64 (C), 48.43 (C), 39.41 (CH), 37.48 (CH2), 33.69 (CH2), 31.89
(CH2), 22.59 (CH3), 20.74 (CH3), 17.11 (CH3). HRMS TOF (ESI+) m/z calculated for C15H21O3 [M + H]+
249.1491, found 249.1483.
2.2.9. Synthesis of Compounds 18 and 19 (See Scheme 6)
To a solution of nootkatone 1 (0.23 mL, 1 mmol) in dry toluene (4 mL) cooled at −78 ◦C, 1.25 mL
of collidine were added and the resulting mixture was stirred for 15 min, then TMSOTf (0.45 mL,
2.5 mmol) was added and stirred for 10 additional min. Upon consumption of the starting material,
the reaction mixture was diluted with hexane (15 mL), washed with brine (3 × 10 mL) and dried over
anhydrous Na2SO4 and concentrated in vacuo. The crude mixture was dissolved in THF (10 mL),
then 4 mL of formaldehyde (37%, water) and Yb(OTf)3 (550 mg, 0.9 mmol) were added under argon
atmosphere and stirred for 24 h. The reaction mixture was then diluted with a solution of saturated
NaHCO3 (60 mL) and extracted with EtOAc (3 × 15 mL). The organic layer was washed with 1N HCl
(3 × 15 mL), brine (3 × 15 mL), dried with anhydrous Na2SO4 and concentrated in vacuo. The crude
reaction mixture was purified by column chromatography using mixtures of solvents with increasing
polarity to obtain 126 mg of 1 (54.7%) (H:MTBE, 9:1), 86 mg of 18 (34%) (H:MTBE, 2:1).and 30 mg of 19
(11%) (H:MTBE, 2:1).
Compound 18. [α]D= +118.0 (c = 1, DCM). 1H NMR (400 MHz, CDCl3) δ = 5.77 (d, J = 1.6 Hz,
1H), 4.73 (bs, 1H), 4.70 (bs, 1H), 4.04 (dd, J = 11.2, 3.1 Hz, 1H), 3.72 (dd, J = 11.4, 6.7 Hz, 1H), 2.49 (dddd,
J = 15.6, 14.0, 5.2, 1.9 Hz, 1H), 2.38–2.28 (m, 3H), 2.00 (dt, J = 13.1, 2.8 Hz, 1H), 1.94–1.88 (m, 2H), 1.71 (s,
3H), 1.33 (qd, J = 12.7, 4.1 Hz, 1H), 1.14 (s, 3H), 1.11 (t, J = 13.0 Hz, 1H), 0.99 (d, J = 6.8 Hz, 3H).13C NMR
(126 MHz, CDCl3) δ = 202.50 (C), 170.84 (C), 148.86 (C), 124.17 (CH), 109.39 (CH2), 60.39 (CH2), 49.18
(CH), 44.04 (CH2), 41.27 (CH), 40.26 (CH), 39.79 (C), 33.05 (CH2), 31.60 (CH2), 20.73 (CH3), 17.25 (CH3),
12.12 (CH3). HRMS TOF (ESI+) m/z calculated for C16H25O2 [M + H]+ 249.1855, found 249.1843.
Compound 19. [α]D= +238.7 (c = 1, DCM). 1H NMR (400 MHz, CDCl3) δ 5.54 (dd, J = 5.2, 2.3 Hz,
1H), 4.77 (bs, 1H), 4.74 (bs, 1H), 4.04 (d, J = 11.7 Hz, 1H), 3.99 (d, J = 11.5 Hz, 1H), 3.93 (d, J = 11.5 Hz,
1H), 3.72 (d, J = 11.7 Hz, 1H), 2.79 (dd, J = 18.6, 7.8 Hz, 1H), 2.34–2.05 (m, 4H), 1.95 (ddd, J = 17.6, 11.2,
2.3 Hz, 1H), 1.75 (s, 3H), 1.75–1.70 (m, 1H), 1.22 (7, J = 12.5 Hz, 1H), 0.95 (d, J = 6.6 Hz, 3H), 0.86 (s,
3H).13C NMR (126 MHz, CDCl3) δ 218.09 (C), 149.25 (C), 142.18 (C), 122.99 (CH), 109.09 (CH2), 70.60 (2
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x CH2), 57.81 (C), 44.22 (CH2), 41.14 (CH2), 38.08 (C), 37.28 (CH), 36.62 (CH), 31.18 (CH2), 20.71 (CH3),
17.82 (CH3), 15.26 (CH3). HRMS TOF (ESI+) m/z calculated for C17H27O3 [M + H]+ 279.1960, found
279.1950.
2.2.10. Synthesis of Compound 20
To a solution of 18 (75 mg, 0.3 mmol) in dry TFH (2.5 mL), 0.13 mL of n-Bu3P (0.46 mmol) and
1.3 mg of o-NO2PhSeCN (0.46 mmol) were added under argon atmosphere and the resulting solution
was stirred for 80 min at room temperature. Upon consumption of starting material, the reaction
mixture was diluted with MTBE (10 mL), was washed with saturated NH4Cl (3 × 5 mL), brine (3 ×
5 mL), dried with anhydrous Na2SO4, and concentrated in vacuo. The crude reaction mixture was
dissolved in THF (30 ml) and 30% H2O2 (0.06 mL, 0.48 mmol) was added under argon atmosphere.
The resulting mixture was stirred for 15 min at room temperature. Upon consumption of the starting
material, the reaction mixture was diluted with MTBE (30 mL), washed with brine (3 x 20 mL),
dried with anhydrous Na2SO4, and concentrated in vacuo and purified by flash chromatography (H:
MTBE, 1:2) to obtain 48 mg of 20 (71%).
Compound 20. [α]D= +149.2 (c = 1, DCM). 1H NMR (400 MHz, CD3COCD3) δ 5.92 (s, 1H), 5.80
(s, 1H), 5.22 (s, 1H), 4.75 (bs, 1H), 4.73 (bs, 1H), 2.67–2.53 (m, 2H), 2.44 (ddd, J = 15.3, 4.1, 2.8 Hz, 1H),
2.37 (tt, J = 12.6, 3.3 Hz, 1H), 2.03–1.98 (m, 1H), 1.95–1.87 (m, 1H), 1.75 (s, 3H), 1.42–1.25 (m, 2H), 1.14
(d, J = 6.7, 0.9 Hz, 3H), 1.02 (s, 3H). 13C NMR (101 MHz, CD3COCD3) δ 187.79 (C), 170.28 (C), 149.29
(C), 147.31 (C), 124.13 (CH), 116.87 (CH2), 108.59 (CH2), 46.01 (CH), 43.75 (CH2), 40.95 (C), 40.25 (CH),
32.57 (CH2), 31.31 (CH2), 20.08 (CH3), 17.74 (CH3), 9.70 (CH3). HRMS TOF (ESI+) m/z calculated for
C16H23O [M + H]+ 231.1749, found 231.1739.
2.2.11. Synthesis of Compounds 21 and 22 (See Scheme 7)
To solution of 8 (290 mg, 1.05 mmol) in dry toluene (5 mL) cooled at −78 ◦C, 1.5 mL of collidine was
added under argon atmosphere and the resulting mixture was stirred for 15 min at room temperature,
then 0.47 mL of TMSOTf (2.5 mmol) were added and stirred for another 10 min. The reaction mixture
was diluted in hexane (20 mL) and was washed with brine (3 × 15 mL), dried with anhydrous Na2SO4,
and concentrated in vacuo. The crude mixture was dissolved in dry THF (10 mL), and then 5 mL
of formaldehyde (37% water solution) and 1 g of Yb(OTf)3 (1.6 mmol) were added under argon
atmosphere and stirred for 24 h at room temperature. Upon consumption of the starting material, the
reaction mixture was diluted with 60 mL of saturated NaHCO3 solution and then was extracted with
EtOAc (3 × 35 mL). The combined organic layers were washed with 1N HCl (3 × 20 mL), and brine (3
× 20 mL), dried with anhydrous Na2SO4, and concentrated in vacuo. The crude product was purified
by flash chromatography (H:MTBE, 1:3) to obtain 187 mg of 8 (64.5%) 62 mg of 21 (19.3%) and 22 mg of
22 (6.9%).
Compound 21. [α]D= +111.2 (c = 1, DCM). 1H NMR (400 MHz, CDCl3) δ 5.79 (s, 1H), 5.09 (s, 1H),
4.97 (s, 1H), 4.60 (d, J = 13.6 Hz, 1H), 4.56 (d, J = 13.3 Hz, 1H), 4.06 (dd, J = 11.4, 3.1 Hz, 1H), 3.73 (dd, J
= 11.4, 6.6 Hz, 1H), 2.86 (sa, 1H), 2.52 (dddd, J = 15.5, 13.8, 5.1, 1.9 Hz, 1H), 2.43–2.28 (m, 3H), 2.10 (s,
3H), 2.09–2.05 (m, 1H), 2.02–1.89 (m, 2H), 1.37 (qd, J = 12.8, 4.2 Hz, 1H), 1.15 (s, 3H), 1.14–1.09 (m, 1H),
1.00 (d, J = 6.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 202.27 (C), 170.66 (C), 170.05 (C), 147.21 (C),
124.35 (CH), 112.03 (CH2), 66.03 (CH2), 60.25 (CH2), 49.19 (CH), 44.27 (CH2), 41.16 (CH), 39.83 (C),
36.29 (CH), 32.97 (CH2), 31.77 (CH2), 20.96 (CH3), 17.14 (CH3), 12.12 (CH3). HRMS TOF (ESI+) m/z
calculated for C18H27O4 [M + H]+ 307.1909, found 307.1950.
Compound 22. [α]D= +18.1 (c = 1, DCM). 1H NMR (400 MHz, CDCl3) δ 5.84 (s, 1H), 5.11 (s, 1H),
4.99 (s, 1H), 4.63-4.55 (m, 2H), 3.90 (dd, J = 10.8, 9.6 Hz, 1H), 3.72 (dd, J = 10.8, 3.9 Hz, 1H), 2.69–2.60
(m, 1H), 2.56–2.47 (m, 2H), 2.36 (ddd, J = 13.5, 4.3, 2.7 Hz, 1H), 2.11 (s, 3H), 2.10–2.02 (m, 2H), 1.89 (dt, J
= 13.0, 3.1 Hz, 1H), 1.45 (t, J = 12.6 Hz, 1H), 1.43–1.32 (m, 1H), 1.15 (s, 3H), 1.00 (d, J = 7.1 Hz, 3H).
13C NMR (126 MHz, CDCl3) δ 202.64 (C), 170.67 (C), 170.05 (C), 146.85 (C), 122.97 (CH), 112.15 (CH2),
66.06 (CH2), 61.07 (CH2), 52.39 (CH), 44.42 (CH2), 41.58 (CH), 39.97 (C), 36.15 (CH), 33.36 (CH2), 33.02
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(CH2), 21.01 (CH3), 20.96 (CH3), 11.47 (CH3). HRMS TOF (ESI+) m/z calculated for C18H27O4 [M + H]+
307.1909, found 307.1925.
2.2.12. Synthesis of Compound 23 (See Scheme 7)
A solution of 21 (20 mg, 0.06 mmol) was stirred in 0.5 mL deuterated chloroform (HCl: 0.01%)
for 7 days at 4 ◦C. Then, the solvent was evaporated, and the crude mixture was purified by flash
chromatography (H:MTBE, 1:3) to obtain 11 mg of 23 (66.7%) and 6 mg of 21 (30%).
Compound 23: [α]D= +99.8 (c = 1, DCM). 1H NMR (600 MHz, CDCl3) δ 6.07 (s, 1H), 5.89 (s, 1H),
5.25 (s, 1H), 5.10 (s, 1H), 4.99 (s, 1H), 4.60 (d, J = 13.5 Hz, 1H), 4.57 (d, J = 13.3 Hz, 1H), 2.62–2.7 (m,
1H), 2.51–2.44 (m, 2H), 2.37–2.31 (m, 1H), 2.10 (s, 3H), 2.03 (dt, J = 13.1, 2.8 Hz, 1H), 1.99–1.93 (m,
1H), 1.40 (qd, J = 12.8, 4.6 Hz, 1H), 1.25 (t, J = 12.9 Hz, 1H), 1.12 (d, J = 6.8 Hz, 3H), 0.99 (s, 3H). 13C
NMR (151 MHz, CDCl3) δ 189.41 (C), 170.68 (C), 170.20 (C), 147.34 (C), 146.45 (C), 124.81 (CH), 118.74
(CH2), 111.93 (CH2), 66.02 (CH2), 45.96 (CH), 44.05 (CH2), 41.19 (C), 36.53 (CH), 32.99 (CH2), 29.67
(CH2), 20.95 (CH3), 18.24 (CH3), 10.32 (CH3). HRMS TOF (ESI+) m/z calculated for C18H25O3 [M + H]+
289.1804, found 289.1836.
2.3. Antifeedant Activity
Insect colonies maintained at ICA-CSIC were used for conducting the bioassays. M. persicae
and R. padi were reared on bell pepper (Capsicum annuum) and Hordeum vulgare plants, respectively,
and maintained at 22 ± 1 ◦C and >70% relative humidity, with a photoperiod of 16:8 h (L:D) in
a growth chamber.
Antifeedant bioassays: The upper surface of C. anuum and H. vulgare leaf disks or fragments
(1.0 cm2) were treated with 10 µl of the test substance. The products were tested at an initial dose of
5 mg/ml (50 µg/cm2) respectively. Twenty ventilated plastic boxes (2 × 2 cm) with 10 apterous aphid
adults (24–48 h old) each were allowed to feed in a growth chamber (24 h, environmental conditions
as above). Each experiment was repeated 2 (SE < 10%) and terminated after 24 h. Aphid settling
was measured by counting the number of aphids on each leaf fragment. Settling inhibition (%FI or
%SI) was calculated as % FI / %SI = [1 − (T/C) × 100], where T and C represent settling on treated
and control leaf disks, respectively. The antifeedant effects (% SI) were analyzed for significance
by the nonparametric Wilcoxon signed-rank test. Extracts and compounds with an SI > 70% were
further tested in a dose-response experiment (3–4 serial dilutions) to calculate their relative potency
(EC50, the effective dose to give a 50% settling reduction) from linear regression analysis (% FI/SI on
Log-dose) [27].
2.4. Ixodicidal Activity
H. lusitanicum engorged female ticks were collected in central Spain (Finca La Garganta, Ciudad
Real) from their host (deer) and maintained at 22–24 ◦C and 70% RH until oviposition and egg
hatching. Resulting larvae (4–6 weeks old) were used for the bioassays [12]. Briefly, 50 µL of test
solution were added to 25 mg of powdered cellulose at different concentrations (initial concentration
of 10 mg/ml) and the solvent was evaporated. For each test, three replicates with 20 larvae each were
used. Dead ticks were counted after 24 h of contact with the treated cellulose at the environmental
conditions described, using a binocular magnifying glass. The larvicidal activity data are presented as
percent mortality corrected according to Schneider–Orelli’s formula. Effective lethal doses (LC50 and
LC90) were calculated by Probit Analysis (5 serial dilutions, STATGRAPHICS Centurion XVI, version
16.1.02, Statgraphics Technologies, Inc., P.O. Box 134, The Plains, Virginia 20198, USA).
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3. Results and Discussion
3.1. Synthesis of Nootkatone Derivatives
The generation of chemical diversity from nootkatone (1) started by subjecting this molecule to
the iodine/DMSO dehydrogenating system [28,29]. The reaction of 1 with 0.1 equiv of I2 and 5 equiv
of DMSO in refluxing toluene led to the production of three dehydrogenated products 2–4 (Table 1,
entry 1). Under these conditions, dienone 3 was obtained as the major compound [23]. Compound
2 is a natural component of grapefruit juice [22]. Compound 4 is described for the first time here.
Its stereochemistry at C3 was assigned based on the proton J value (J = 12.5 Hz) of the proton at
this position.
Table 1. Reaction of nootkatone with the dehydrogenating system I2/DMSO.
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Entry Iodine (equiv) Time (h) 2 3 4
1 0.1 30 14 51 16
2 0.2 6 50 28 –
3 1 2 28 6 25
When 0.2 mmol of I2 were used (Table 1, entry 2), the same mixture of compounds was obtained,
with compound 2 being the main reaction product (50% yield). When the quantity of I2 increased to
1 m ol (Table 1, entry 3), a different proportion of the same mixture 2–4 was obtained, with compounds
2 (28%) and 4 (25%) being then the main reaction products. A mechanistic proposal for the formation
of these substances is shown in Scheme 1. Thus, when 1 reacts via Ia, compounds 2 and 4 are obtained,
whereas if Ib is the reacting species, the process leads to the generation of 3.
Biomolecules 2019, 9, x FOR PEER REVIEW 8 of 16 
 
stereochemistry at C3 was assigned based on the proton J value (J = 12.5 Hz) of the proton at this 
position. 
Table 1. Reaction of nootkatone with the dehydrogenating system I2/DMSO. 
 
Entry Iodine (equiv) Time (h) 2 3 4 
1 0.1 30 14 51 16 
2 0.2 6 50 28 – 
3 1 2 28 6 25 
When 0.2 mmol of I2 were used (Table 1, entry 2), the same mixture of compounds was obtained, 
with compound 2 being the main reaction product (50% yield). When the quantity of I2 increased to 
1 mmol (Table 1, entry 3), a different proportion of the same mixture 2–4 was btained, with 
compounds 2 (28%) and 4 (25%) being then the main reaction products. A echanistic proposal for 
the formation of these substances is shown in Scheme 1. Thus, when 1 reacts via Ia, compounds 2 and 
4 are obtained, whereas if Ib is the reacting species, the process leads to the generation of 3. 
 
Scheme 1. Proposed mechanism for the generation of 2–4. 
The regioselective dehydrogenation of nootkatone also afforded dienone 3 (62%) after its 
treatment with DDQ/AcOH in benzene. 
The oxidation of 1 with SeO2 in refluxing EtOH for 3 h led to compounds 5–7 (Scheme 2), with 
alcohol 5 being the major product. Compound 7 was formed after allylic oxidation at C7 and 
subsequent Michael addition of this hydroxyl group to C10. Alcohol 5 is a natural product isolated 
Scheme 1. Proposed mechanism for the generation of 2–4.
Biomolecules 2019, 9, 742 9 of 16
The regioselective dehydrogenation of nootkatone also afforded dienone 3 (62%) after its treatment
with DDQ/AcOH in benzene.
The oxidation of 1 with SeO2 in refluxing EtOH for 3 h led to compounds 5–7 (Scheme 2),
with alcohol 5 being the major product. Compound 7 was formed after allylic oxidation at C7 and
subsequent Michael addition of this hydroxyl group to C10. Alcohol 5 is a natural product isolated
from Alpinia oxyphylla [30], and it was also found in P450-catalyzed transformations of nootkatone [31].
Compound 6 was previously synthesized from nootkatone by a photochemical process [24].
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and 12 [26] was obtained along with diepoxide 13, generated via the Baeyer–Villiger oxidation of the
C1–C2 bond of diepoxide 12 (Scheme 4).
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treatment of 1 with TMSOTf (tri ethylsilyl trifluoro ethanesulfonate) and collidine to produce the
TMS-dienol intermediate I, which after a Rubottom oxidation [34] evolved towards the corresponding
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As happened with 4, the stereochemistry at C3 of alcohols 14 and 15 was determined on the basis
of the coupling constant values measured for H3 (14: H3, d, J = 12.7; 15: H3, d J = 5.2): Additionally,
the correlations observed in the 2D NOESY spectrum of 14 confirmed this assignment (Figure 3).
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Starting from 18, the elimination of the hydroxyl group was achieved in two steps following the Grieco
protocol [36] to obtain a good yield of dienone 20 in good (71%) (Scheme 6).Biomolecules 2019, 9, x FOR PEER REVIEW 11 of 16 
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The enhancements observed in the selective 1D NOESY of 21 allowed us to assign the
stereochemistry of this compound at C3 (Figure 5).Biomolecules 2019, 9, x FOR PEER REVIEW 12 of 16 
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3.2. Antifeedant Activity 
Table 2 shows the results of the aphid antifeedant effects of nootkatone (1) and derivatives. These 
compounds were also tested against the lepidopteran S. littoralis without significant effects (all EC50 
> 50). The most active compounds were 20 (both species), 15 and 2 (R. padi) followed by 7, 10 (M. 
persicae), 3 (R. padi) and 14 (both species). All these derivatives were more active than nootkatone (1), 
with 20, 15 and 2 being over 50% more potent, followed by 10, 7, and 11 (∼50%) (Figure 6).  
Table 2. Insect antifeedant effects of nootkatone (1) and derivatives 2–23 against aphids. 
Product 
M. persicae R. padi 
50 (µg /cm2) a EC50 b 50 (µg /cm2) a EC50 b 
1 50.7 ± 9.1 ∼50 57.7 ± 10.2 ∼50 
2 35.4 ± 9.0 >50 86.0 ± 3.6 * 17.4 (14.4–20.9) 
3 24.6 ± 7.5 >50 77.1 ± 4.5 * 27.1 (20.7–35.4) 
5 49.4 ± 10.9 ∼50 40.9 ± 8.2 >50 
6 57.2 ± 10.1 ∼50 30.7 ± 6.8 >50 
7 79.9 ± 5.4 * ∼25 30.8 ± 6.5 >50 
8 37.8 ± 9.8 >50 31.4 ± 5.9 >50 
9 34.2 ± 8.5 >50 44.2 ± 9.2 >50 
10 80.6 ± 4.8 * 23.5 (16.6–33.3) 36.95 ± 8.5 >50 
11 49.0 ± 9.4 ∼50 69.4 ± 7.6 * ∼25 
12 59.1 ± 7.0 ∼50 51.8 ± 5.7 ∼50 
13 29.0 ± 4.5 >50 19.85 ± 6.5 >50 
14 91.2 ± 5.3 * 30–40 83.8 ± 4.9 * 30–40>50 
15 54.5 ± 8.0 ∼50 78.81 ± 4.4 8.3 (5.5–12.7) 
16 63.9 ± 7.4 * ∼50 37.3 ± 7.3 >50 
17 40.6 ± 6.9 >50 34.2 ± 7.9 >50 
18 60.4 ± 7.1 * ∼50 44.4 ± 9.0 >50 
19 35.4 ± 7.6 >50 19.8 ± 5.6 >50 
20 92.1± 2.5 ** 16.3 (13.6–19.7) 93.9 ± 4.2 * 7.1 (5.4–9.4) 
23 62.3 ± 9.2 ∼50 17.5 ± 6.7 >50 
a Percent settling inhibition (%SI, n = 100 insects). b Dose needed to give 50% settling inhibition (95% Confidence 
Limits). * Significantly different from the control (p < 0.05), Wilcoxon paired rank test. 
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Table 2 shows the results of the aphid antifeedant effects of nootkatone (1) and derivatives.
These compounds were also tested against the lepidopteran S. littoralis without significant effects
(all EC50 > 50). The most active compounds were 20 (both species), 15 and 2 (R. padi) followed by 7,
10 (M. persicae), 3 (R. padi) and 14 (both species). All these derivatives were more active than nootkatone
(1), with 20, 15 and 2 being over 50% more potent, followed by 10, 7, and 11 (~50%) (Figure 6).
It should be noticed that the α,β-unsaturated ketone 20, with an extra methylene, 15 with
an α-hydroxy at C-3 and 2, with an additional endocyclic C8–C9 unsaturation, exhibited strong
antifeedant effects followed by the exocyclic epoxide 7, and the aldehyde derivative 10. The presence of
an additional Michael acceptor in compound 20 may account for the observed bioactivity of this product.
In this regard, previous results showed that the presence of an exocyclic epoxide in eremophilanes
resulted in strong antifeedant effects against M. persicae and S. littoralis [12].
Table 2. Insect antifeedant effects of nootkatone (1) and derivatives 2–23 against aphids.
Product
M. persicae R. padi
50 (µg /cm2) a EC50 b 50 (µg /cm2) a EC50 b
1 50.7 ± 9.1 ~50 57.7 ± 10.2 ~50
2 35.4 ± 9.0 >50 86.0 ± 3.6 * 17.4 (14.4–20.9)
3 24.6 ± 7.5 >50 77.1 ± 4.5 * 27.1 (20.7–35.4)
5 49.4 ± 10.9 ~50 40.9 ± 8.2 >50
6 57.2 ± 10.1 ~50 30.7 ± 6.8 >50
7 79.9 ± 5.4 * ~25 30.8 ± 6.5 >50
8 37.8 ± 9.8 >50 31.4 ± 5.9 >50
9 34.2 ± 8.5 >50 44.2 ± 9.2 >50
10 80.6 ± 4.8 * 23.5 (16.6–33.3) 36.95 ± 8.5 >50
11 49.0 ± 9.4 ~50 69.4 ± 7.6 * ~25
12 59.1 ± 7.0 ~50 51.8 ± 5.7 ~50
13 29.0 ± 4.5 >50 19.85 ± 6.5 >50
14 91.2 ± 5.3 * 0 40 83.8 ± 4.9 * 30–40>50
15 54.5 ± 8.0 ~50 78.81 ± 4.4 8.3 (5.5–12.7)
16 63.9 ± 7.4 * ~50 37.3 ± 7.3 >50
17 40.6 ± 6.9 >50 34.2 ± 7.9 >50
18 60.4 ± 7.1 * ~50 44.4 ± 9.0 >50
19 35.4 ± 7.6 >50 19.8 ± 5.6 >50
20 92.1± 2.5 ** 16.3 (13.6–19.7) 93.9 ± 4.2 * 7.1 (5.4–9.4)
23 62.3 ± 9.2 ~50 17.5 ± 6.7 >50
a Percent settling inhibition (%SI, n = 100 insects). b Dose needed to give 50% settling inhibition (95% Confidence
Limits). * Significantly different from the control (p < 0.05), Wilcoxon paired rank test.
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3.3. Ixodicidal Activity
Table 3 shows the ixodicidal effects of nootkatone (1) and derivatives against H. lusitanicum larvae.
Table 3. Acaricidal activity of nootkatone (1) and derivatives 2–23 against H. lusitanicum larvae.
Product % Mortality a (20 µg/mg)
Lethal Dose (µg/mg) b
LD50 LD90
1 85.9 ± 2.2 4.02 (1.92–7.42) 18.02 (13.60–29.16)
2 100 ± 0 5.36 (4.94–5.90) 4.31(3.93–4.82)
3 98.3 ± 0.4 2.94 (2.54–3.38) 5.72 (5.0–6.80)
5 100 ± 0 0.96 (0.88–1.04) 1.28 (1.18–1.38)
6 47.3 ± 14.3
7 100 ± 0 5.04 (4.56–5.64) 8.04 (7.20–9.22)
8 32.2 ± 3.0
9 42.6 ± 2.2
10 8.5 ± 1.0
11 88.5 ± 1.6 5.60 (4.88–6.44) 10.84 (9.50–12.8)
12 1.5 ± 1.6
13 7.7 ± 10.8
14 46.3 ± 8.7
15 100 ± 0 8.74 (8.10–9.40) 11.52 (10.68–12.8)
16 23.4 ± 3.5
17 11.7 ± 7.3
18 96.7 ± 1.6 7.06 (6.20–8.10) 12.94 (11.34–15.36)
19 17.7 ± 1.3
20 100 ± 0 1.34 (1.20–1.50) 2.14 (1.92–2.44)
23 11.5 ± 1.3
a Mortality data corrected according to Schneider–Orelli’s formula. b Doses needed to give 50 and 90% mortality
(95% Confidence Limits).
Using the activity of nootkatone as reference, the tested compounds can be classified in four
groups according to their relative activity (Figure 7). Compounds 5, 20 (>50%) and 3 (20 and 68%)
showed an increase in acaricidal activity with respect to nootkatone (1) for both lethal doses (Table 3,
Figure 5); followed by 2, 7 and 11 with an increase for LD90 >50%. Compounds 15 and 18 showed
reduced acaricidal potency at LD50 and higher at LD90 than 1. Lastly, the remaining compounds either
displayed a significant loss of activity or were not active at all. These results are relevant considering
Biomolecules 2019, 9, 742 14 of 16
that nootkatone was reported to be more active against the tick species Ixodes scapularis and Amblyomma
americanum than Permanone, a permethrin-based commercial clothing repellent [37].
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4. Conclusions 
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